News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
February 11, 2025
·
6 min read
Press Releases
Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema
February 11, 2025
·
5 min read
Press Releases
MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line
February 11, 2025
·
8 min read
Press Releases
Biophytis Unveils Its Outlook Strategies for 2025
February 11, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
February 11, 2025
·
6 min read
Press Releases
Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors
February 10, 2025
·
5 min read
Press Releases
Restart Life Sciences Corp. Relies on Exception Under CSE Policy 4.6(2)(b) for Previously Closed Private Placement and Debt Settlement Transactions and Announces Debt Settlement Transaction
February 7, 2025
·
3 min read
Press Releases
Izotropic Announces Non-Brokered Private Placement
February 7, 2025
·
3 min read
Press Releases
InFlectis BioScience Announces Promising Results for IFB-088 in a Phase 2a Clinical Study in Bulbar-Onset ALS Patients
February 6, 2025
·
3 min read
Press Releases
Izotropic Reschedules Investor Conference Presentation to March 13th
February 6, 2025
·
2 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us